ヒト胚性幹細胞（hESC）調査の世界市場

ヒト胚性幹細胞（hESC）調査の世界市場は2030年までに14億米ドルに達する見込み

2023年に9億550万米ドルと推定されたヒト胚性幹細胞（hESC）調査の世界市場は、2023年から2030年にかけてCAGR 6.4%で成長し、2030年には14億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである再生医療アプリケーションは、CAGR 6.5%を記録し、分析期間終了時には9億8,850万米ドルに達すると予測されます。幹細胞生物学研究応用分野の成長率は、分析期間中CAGR 7.2%と推定されます。

米国市場は2億4,110万米ドルと推定、中国はCAGR6.0%で成長すると予測

米国のヒト胚性幹細胞（hESC）調査市場は、2023年に2億4,110万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年にかけてCAGR 6.0%で推移し、2030年には2億1,930万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.7%と5.3%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界のヒト胚性幹細胞（hESC）調査市場- 主要動向と促進要因のまとめ

ヒト胚性幹細胞（hESC）は再生医療の要であり、遺伝性疾患から変性疾患まで幅広い疾患の治療において前例のない可能性を提供します。20年以上前に発見されたこの細胞は多能性であり、人体内のほぼすべての細胞型に分化することができます。このユニークな能力により、医療への応用は非常に貴重なものとなっているが、ヒト胚から誘導されるため、その使用には倫理的な懸念があります。この分野における進歩は、hESCの培養に動物由来の成分を使用することから、ゼノフリーでヒト由来の材料へとシフトし、臨床現場での適用性を高めています。このシフトには、ヒト由来材料を用いてhESCを制御された環境で増殖させるフィーダーフリー培養システムの開発も含まれ、コンタミネーションのリスクを最小限に抑えながら、これらの細胞の未分化状態を維持するために不可欠です。

hESCを治療応用に必要な特定の細胞型に分化させる過程では、培養条件を複雑に操作する必要があります。これには、特定の成長因子の使用、三次元足場、他の細胞種との共培養などが含まれ、神経細胞や心臓細胞など、望ましい系統への成長を誘導します。しかし、分化過程には、細胞誘導の非効率性や、残存する未分化細胞による腫瘍形成の危険性などの課題がつきまとう。さらに、ヒトの組織は複雑な性質を持っているため、細胞の正確な発生と宿主組織への統合を確実にするためには、ますます洗練されたin vitroモデルが必要となります。このようなハードルにもかかわらず、現在進行中の調査や臨床試験は、hESCの膨大な治療可能性を実証し続けており、これまで治療選択肢が限られていた様々な疾患への応用が期待されています。

将来に向けて、hESC研究分野は、幹細胞治療の科学的進展と社会的受容を高めるいくつかの重要な成長要因に牽引されています。三次元培養技術の革新は、研究や治療におけるhESCの生存能力を著しく向上させました。CRISPR/Cas9のような遺伝子編集技術の自動化と進歩は、細胞培養と遺伝子改変のプロセスを洗練させ、治療をより個別化し、免疫拒絶反応のリスクを軽減しています。加えて、合成培養やゼノフリー培養への移行は、幹細胞治療を規制基準に合致させ、臨床使用における安全性を高めています。一般の人々の認識や倫理的な配慮の発展が、法制度の枠組みを形成し続け、研究を促進し、hESC治療の医療への応用を広げています。国際的な協力と標準化の努力は、官民両部門からの多額の資金援助と相まって、研究のペースを加速させ、さまざまな病状におけるhESCの治療可能性を拡大しています。これらの要因が相まって、医学と倫理的実践の限界を押し広げ続ける、ダイナミックで急速に進歩する分野が育まれています。

調査対象企業の例（全24件）

• Astellas Institute of Regenerative Medicine
• Asterias Biotherapeutics, Inc.
• BD Biosciences
• Cell Cure Neurosciences Ltd.
• Cellular Dynamics International
• GE Healthcare
• PerkinElmer, Inc.
• Reliance Life Sciences Ltd.
• Research & Diagnostics Systems, Inc.
• STEMCELL Technologies, Inc.
• Stemina Biomarker Discovery, Inc.
• Takara Bio, Inc.
• TATAA Biocenter AB
• Thermo Fischer Scientific Inc.
• UK Stem Cell Bank
• ViaCyte, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• その他欧州
• アジア太平洋
• 世界のその他の地域

第4章 競合

Global Human Embryonic Stem Cell (hESC) Research Market to Reach US$1.4 Billion by 2030

The global market for Human Embryonic Stem Cell (hESC) Research estimated at US$905.5 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$988.5 Million by the end of the analysis period. Growth in the Stem Cell Biology Research Application segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.1 Million While China is Forecast to Grow at 6.0% CAGR

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$241.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Human Embryonic Stem Cell (hESC) Research Market - Key Trends and Drivers Summarized

Human embryonic stem cells (hESCs) represent a cornerstone of regenerative medicine, offering unprecedented potential in the treatment of a broad spectrum of diseases, from genetic disorders to degenerative conditions. Discovered over two decades ago, these cells are pluripotent, capable of differentiating into almost any cell type in the human body. This unique ability makes them invaluable for medical applications, though their use raises ethical concerns due to their derivation from human embryos. Advances in the field have shifted from using animal-based components to xeno-free and human-derived materials for cultivating hESCs, enhancing their applicability in clinical settings. This shift includes the development of feeder-free culture systems that allow hESCs to grow in controlled environments using human-sourced materials, which is critical for maintaining the undifferentiated state of these cells while minimizing the risk of contamination.

The process of directing hESCs to differentiate into specific cell types necessary for therapeutic applications involves intricate manipulation of their culturing conditions. This includes the use of specific growth factors, three-dimensional scaffolding, and co-cultures with other cell types to guide their growth into desired lineages, such as neuronal or cardiac cells. However, the differentiation process is fraught with challenges, including inefficiencies in directing cells and the risk of tumorigenicity from residual undifferentiated cells. Moreover, the complex nature of human tissues requires increasingly sophisticated in vitro models to ensure accurate cell development and integration into host tissues. Despite these hurdles, ongoing research and clinical trials continue to demonstrate the vast therapeutic potential of hESCs, addressing a range of conditions with previously limited treatment options, thus highlighting both the scientific promise and the ethical and regulatory complexities associated with their use.

Looking forward, the hESC research field is driven by several key growth factors that enhance both scientific advancement and public acceptance of stem cell therapies. Innovations in three-dimensional culturing technologies have significantly improved the viability of hESCs in research and therapeutic contexts. Automation and advancements in gene-editing technologies, like CRISPR/Cas9, have refined the processes of cell culturing and genetic modification, making treatments more personalized and reducing the risk of immune rejection. Additionally, the transition to synthetic and xeno-free culturing components has aligned stem cell therapies with regulatory standards and increased their safety for clinical use. Public awareness and evolving ethical considerations continue to shape legislative frameworks, facilitating research and broadening the application of hESC therapies in medicine. International collaboration and standardization efforts, coupled with substantial funding from both public and private sectors, are accelerating the pace of research and expanding the therapeutic potential of hESCs across a wide array of medical conditions. These factors collectively foster a dynamic and rapidly advancing field that continues to push the boundaries of medical science and ethical practice.

Select Competitors (Total 24 Featured) -

• Astellas Institute of Regenerative Medicine
• Asterias Biotherapeutics, Inc.
• BD Biosciences
• Cell Cure Neurosciences Ltd.
• Cellular Dynamics International
• GE Healthcare
• PerkinElmer, Inc.
• Reliance Life Sciences Ltd.
• Research & Diagnostics Systems, Inc.
• STEMCELL Technologies, Inc.
• Stemina Biomarker Discovery, Inc.
• Takara Bio, Inc.
• TATAA Biocenter AB
• Thermo Fischer Scientific Inc.
• UK Stem Cell Bank
• ViaCyte, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Human Embryonic Stem Cell (hESC) Research - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Breakthroughs in Regenerative Medicine Expand Addressable Market Opportunity
  • Rising Prevalence of Chronic Diseases Drives Demand for hESC-Based Therapies
  • Advances in Genomic Editing Propel Growth
  • Technological Innovations in Cell Culture Techniques Accelerate Market Growth
  • Integration of AI and Machine Learning in Stem Cell Research Throws the Spotlight on Precision Medicine
  • Rising Investments in Biotechnology Sustain Growth in hESC Research
  • Growing Focus on Personalized Medicine Drives Innovation in hESC Therapies
  • Challenges in Ethical Considerations and Public Perception Impact Market Dynamics
  • Emerging Applications in Drug Discovery and Toxicology Testing Create Growth Opportunities
  • Increasing Use of hESCs in Neurological Disorder Treatments Generates Demand
  • Evolution of 3D Bioprinting Technology Spurs Demand for hESCs in Tissue Engineering
  • Expansion of Biopharmaceutical Industry Boosts Innovation in hESC Research
  • Advances in Cryopreservation Techniques Strengthen Viability of hESCs
  • Novel Applications in Cardiovascular Disease Treatments Propel Growth of hESC Research
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Human Embryonic Stem Cell (hESC) Research Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 12: USA Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 13: USA 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Canada 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• JAPAN
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 16: Japan Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: Japan 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• CHINA
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 18: China Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: China 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• EUROPE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 20: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 22: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• FRANCE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 24: France Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: France 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• GERMANY
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 26: Germany Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Germany 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• ITALY
  • TABLE 28: Italy Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Italy 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• UNITED KINGDOM
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 30: UK Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: UK 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Rest of Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• ASIA-PACIFIC
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Asia-Pacific 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 37: Rest of World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030

IV. COMPETITION